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The burden of respiratory infections among
older adults in long-term care: a systematic
review
Arielle Childs1,2, Andrew R. Zullo1,2,3* , Nina R. Joyce1,2, Kevin W. McConeghy2,3, Robertus van Aalst4,5,
Patience Moyo2, Elliott Bosco2, Vincent Mor2,3 and Stefan Gravenstein2,3
Abstract
Background: Respiratory infections among older adults in long-term care facilities (LTCFs) are a major global concern,
yet a rigorous systematic synthesis of the literature on the burden of respiratory infections in the LTCF setting is
lacking. To address the critical need for evidence regarding the global burden of respiratory infections in LTCFs, we
assessed the burden of respiratory infections in LTCFs through a systematic review of the published literature.
Methods: We identified articles published between April 1964 and March 2019 through searches of PubMed
(MEDLINE), EMBASE, and the Cochrane Library. Experimental and observational studies published in English that
included adults aged ≥60 residing in LTCFs who were unvaccinated (to identify the natural infection burden), and that
reported measures of occurrence for influenza, respiratory syncytial virus (RSV), or pneumonia were included.
Disagreements about article inclusion were discussed and articles were included based on consensus. Data on study
design, population, and findings were extracted from each article. Findings were synthesized qualitatively.
Results: A total of 1451 articles were screened for eligibility, 345 were selected for full-text review, and 26 were included.
Study population mean ages ranged from 70.8 to 90.1 years. Three (12%) studies reported influenza estimates, 7 (27%)
RSV, and 16 (62%) pneumonia. Eighteen (69%) studies reported incidence estimates, 7 (27%) prevalence estimates, and 1
(4%) both. Seven (27%) studies reported outbreaks. Respiratory infection incidence estimates ranged from 1.1 to 85.2%
and prevalence estimates ranging from 1.4 to 55.8%. Influenza incidences ranged from 5.9 to 85.2%. RSV incidence
proportions ranged from 1.1 to 13.5%. Pneumonia prevalence proportions ranged from 1.4 to 55.8% while incidence
proportions ranged from 4.8 to 41.2%.
Conclusions: The reported incidence and prevalence estimates of respiratory infections among older LTCF residents
varied widely between published studies. The wide range of estimates offers little useful guidance for decision-making
to decrease respiratory infection burden. Large, well-designed epidemiologic studies are therefore still necessary to
credibly quantify the burden of respiratory infections among older adults in LTCFs, which will ultimately help inform
future surveillance and intervention efforts.
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Background
Acute respiratory infections cause approximately 4 million
deaths per year globally [1]. In the United States, influenza,
pneumonia, and respiratory syncytial virus (RSV) are pro-
jected to infect more than 13 million people annually, with
an associated mortality burden of 69,000 to nearly 100,000
deaths attributable to just influenza in the 2017–2018 sea-
son alone [2–4]. Due to age-related characteristics like
frailty and immunosenescence, respiratory infections pro-
duce more severe illness, a larger number of hospitaliza-
tions, and greater mortality in older than in younger adults
[5, 6]. From the years 2012 to 2050, the size of the popula-
tion of individuals ≥65 years is expected to double [7]. This
growth creates a critical need to better understand the bur-
den of respiratory infections in older adults [7].
Older adults residing in long-term care facilities (LTCFs)
are an important subset of the older adult population that is
at high risk of respiratory infections. Around 5% or more of
persons ≥65 years are in LTCFs in developed countries, and
LTCF use is rapidly growing in developing countries [8, 9].
These LTCFs house individuals in close quarters, an import-
ant consideration for contagious respiratory infections [10,
11]. The close proximity of residents in combination with
advanced age, multimorbidity and frailty in LTCFs likely pre-
disposes older adults to an even greater susceptibility to in-
fections and their complications [12]. Furthermore, the
clustering of frail older LTCF residents in close living quar-
ters allows infections to spread more quickly. For diseases
with morbidity and mortality that can be averted through
vaccines, like bacterial pneumonia and influenza, low vaccin-
ation rates can contribute to the development of outbreaks
[13]. Consequently, the LTCF setting and its residents are
important targets for research and interventions [11].
Despite the common belief and plausibility that older
LTCF residents are at a high risk of respiratory infections, to
our knowledge, there has not been a rigorous synthesis of
the existing evidence to empirically identify the burden of
respiratory infections and guide future research or interven-
tions. Nearly all prior studies and reviews have emphasized
community-dwelling older adults, who have a lower preva-
lence of frailty and notably different characteristics. Much of
the prior literature and its synthesis does not directly apply
to LTCF residents. Synthesizing the evidence on LTCF resi-
dents can better inform future research as well as clinical
and policy decision-making for this important population.
To address the need for evidence regarding the global
burden of respiratory infections in LTCFs, we conducted
a systematic literature review to summarize and appraise
the current published literature.
Methods
Scope of the review
This systematic review was designed to understand the
natural burden of respiratory infections (in the absence
of vaccination or other treatment) among older adults in
the LTCF setting.
Data sources and searches
We systematically searched three databases (PubMed,
Embase, and Cochrane Database of Systematic Reviews)
for published systematic reviews on the prevalence and
incidence of influenza, pneumonia, and RSV among LTCF
residents in any country. Systematic reviews published in
English between April 1964 and March 15, 2019 were con-
sidered. We individually evaluated (i.e., “handsearched”)
the reference lists of the reviews to identify relevant articles
to supplement our search for individual articles. We then
systematically searched PubMed and Embase for relevant
individual observational and experimental studies pub-
lished in English during the same period. The database
search strategies included the combination of terms in
Additional file 1: Tables S1 and S2. Conference abstracts or
proceedings were not included.
Study selection
For individual articles, semi-automated abstract screen-
ing was performed using a machine-learning algorithm,
which was trained by four reviewers to prioritize ab-
stracts for screening from highest to lowest relevance
(http://abstrackr.cebm.brown.edu) [14]. Abstracts for in-
dividual articles were independently assessed for inclu-
sion by at least two reviewers.
We only included studies that specified participants to
be aged ≥60 years, or that included a study population
with a mean age ≥ 75 years and a standard deviation
(SD) ≤ 6 years. These criteria reasonably ensured the
study sample would be representative of a population
aged ≥60 since > 95% of individuals could be expected to
have an age ≥ 60 based on a normal distribution [15].
We also required that the study be conducted in a popu-
lation residing in a LTCF setting that was not hospital-
based because such hospital-based facilities typically op-
erate more like an acute-care setting. To isolate the nat-
ural burden of infections in the absence of interventions
and better understand the maximum potential impact
that interventions might have when implemented alone
or in combination, studies were only included if they
provided data on an unvaccinated population which had
not received either influenza or pneumococcal vaccine.
Non-use of both influenza and pneumococcal vaccine
was required due to the complex relationships between
influenza and pneumonia (e.g., bacterial pneumonias in
LTCFs may often result from viral infection that dam-
ages the lung epithelium to make it a rich culture
medium for various bacteria), and the possibility that in-
fluenza vaccination may reduce the incidence of
pneumococcal pneumonia. Similarly, we only included
studies with populations not taking prophylactic antiviral
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medications for influenza (i.e., oseltamivir, zanamivir,
peramivir, amantadine, and rimantadine). Studies exam-
ining RSV had no such requirements because there was
no licensed vaccine for the virus at the time of this re-
view. If a study did not describe vaccination or antiviral
medication use and met all other criteria, we assumed
the study population was unvaccinated or unexposed to
antiviral medications and included the article. We did
not evaluate studies for inclusion based on the method by
which a respiratory infection was characterized because
the various methods were all considered valid. As an ex-
ample, viral testing is uncommonly done to diagnose in-
fluenza as clinicians often make a clinical diagnosis based
on symptoms, judgement, and local influenza activity [16].
Likewise, bacterial pneumonia is also typically a clinical
diagnosis and, in the LTCF setting, empirically treated. It
is noteworthy that the various causes of pneumonia are
essentially clinically indistinguishable from one another
and the likelihood of a correct diagnosis outside of sys-
tematic testing is increased when there is a laboratory-
confirmed case in the context of a cluster of individuals
becoming ill around the same time (i.e., an outbreak).
In addition to studies describing the prevalence and
incidence of influenza, pneumonia, and RSV, we were
also interested in including literature on the outcomes
and costs of such infections in LTCFs. Studies were ex-
cluded if they were case reports, editorials, case series,
or commentaries. We adjudicated disagreements about
exclusions through discussion.
Data extraction and quality assessment
Data were extracted into the Systematic Review Data Re-
pository (https://srdr.ahrq.gov). For each included study, one
reviewer (A.C.) extracted study characteristics and informa-
tion on respiratory infection occurrence, including which-
ever measures of occurrence were available or calculable--
incidence proportion, prevalence proportion, incidence rate,
and prevalence rate. Study characteristics included study de-
sign, geographic location, study dates, inclusion and exclu-
sion criteria specific to the study, and whether the study
focused on an infection outbreak or not. Data about the
study population were also extracted, such as risk factors for
infection and mean age (and whenever possible, SD). In
studies of an intervention that could affect the risk of infec-
tion, data was only extracted from the control group.
Data synthesis and analysis
Study data were synthesized qualitatively. Considering the
relatively small number of studies, inconsistencies between
studies, differences in outcome measures, and heterogen-
eity of the LTCF populations between countries, we elected
not to perform a quantitative synthesis. Due to the nature
of the review questions, we also elected not to perform a
strength of evidence assessment.
Results
Literature search
Our search for existing systematic reviews yielded 46 re-
sults. For the search of individual articles, we screened
1451 citations (Fig. 1). Of those, 345 were selected for
full-text review. No additional articles were identified for
inclusion from Embase after searching PubMed.
Overall study characteristics
We included 26 studies: 3 on influenza, 7 on RSV, and 16
on pneumonia. Fifteen studies were from North American
countries, 6 from Asian countries, and 5 from European
countries. There were 11 prospective cohort studies [17–
27], 10 retrospective cohort studies [28–37], 3 randomized
controlled trials (RCTs) [38–40], and 2 cross-sectional stud-
ies [41, 42]. The mean age of the study populations ranged
from 70.8 to 90.1 years among all but 6 studies that
reported a mean age. Male sex ranged from 16.5 to 54% of
study participants, with no data for 8 studies. The time of
data collection ranged from February 1979 to “winter
2014”, with no information on time of data collection for
one study. The range of study sample sizes was 52 to 102,
842 subjects and follow-up period lengths ranged from 30
days to 4 years. Two studies were industry-funded, 17 were
not industry-funded, and the remaining 7 did not report
the source of funding. Of the included studies, 18 reported
an incidence estimate while only 7 reported a prevalence
estimate; one study reported both. No literature was identi-
fied on the outcomes or costs of developing a respiratory
infection in LTCFs.
Influenza
Three studies provided data on the natural burden of in-
fluenza among LTCF residents (Table 1). Two were
retrospective cohort studies and one was an RCT. All
three studies were conducted before the year 2000. Two
studies specifically reported on outbreaks.
One of the retrospective studies focused on an outbreak
of influenza A in a US LTCF with 170 residents, of which
59 were unvaccinated. Individuals were assessed and
grouped according to two different definitions of infection.
The first definition (definition 1) identified individuals with
more severe symptoms (high fever and either chest
congestion or cough). The second (definition 2) identified
individuals with milder symptoms (high fever or chest con-
gestion or cough). Definition 1 resulted in an incidence of
20.3% and definition 2 an incidence of 47.4% [28]. The
other US retrospective cohort study also focused on an in-
fluenza outbreak and reported an incidence of 85.2%
among 27 unvaccinated LTCF residents [29].
The third influenza study was an RCT that investi-
gated the efficacy of the influenza vaccine among older
adults in Japanese LTCFs [38]. Within the control group
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of 11,723 unvaccinated LTCF residents, the incidence of
influenza was 5.9% [38].
No studies provided prevalence measures. The small
number of influenza studies precluded examining
patterns by geography, study design, or other study
characteristics.
Respiratory syncytial virus
The incidence of RSV among LTCF populations was
evaluated in four prospective cohort studies, two retro-
spective cohort studies, and one RCT (Table 2). Among
these seven studies, six reported incidence proportions
and one reported an incidence rate.
Fig. 1 Flow of the selection process for literature included in the review. Asterisk symbol (*) in Figure indicates that articles could not be
evaluated because they were in not written in English; the full text could not be accessed; or measures of occurrence were not presented and
there were insufficient data to calculate measures of occurrence for infections of interest
Table 1 Published Literature on the Burden of Influenza in Long-term Care Facilities
Author,
Publication Year















December 1, 1982 -
January 4, 1983
Outbreak 86.4 23 / 27 85.2%












temperature≥ 37.8 °C: 12 / 59;
Influenza Definition 2—Chest
congestion or cough or












81.4 694 / 11,723 5.9%
aIf available and unless another measure is specified
bThe estimates and study participants’ characteristics were calculated among the unvaccinated individuals
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Five measures of occurrence were from non-outbreak
studies, with incidence proportions ranging from 1.1 to
10.8%, and an incidence rate of 12.4 cases per 1000 per-
son-years [17, 19, 20, 31, 39]. The two studies focused
on outbreaks reported higher incidence proportions of
12.9 and 13.5% [18, 30].
No studies provided prevalence measures. Incidence did
not appear to differ markedly by geography or study design.
Pneumonia
Seventeen studies reported incidence and prevalence
data for pneumonia in LTCF populations (Table 3). We
identified seven prospective studies, six retrospective
studies, two cross-sectional studies, and one RCT.
The majority of studies were conducted in non-outbreak
settings with incidences ranging from 4.8 to 41.2%. Preva-
lence estimates ranged from 1.4 to 55.8% [21–23, 25–27,
32, 35, 41, 42]. Incidence rates were 0.07 and 0.17 cases per
1000 bed-days, as well as 9.17 cases per 100 person-years
[32, 40]. Incidence rates of 4.61 and 5.21 cases per person-
year were reported for atypical and typical antipsychotic
users, respectively [36]. The incidence proportions were
8.17 and 5.21%, respectively [36]. Among the three out-
break studies, the two incidence estimates were 6.4 and
19.8%, and the prevalence estimate was 5.1% [24, 33, 37].
The burden of pneumonia did not appear to markedly
differ by measure (incidence or prevalence), outbreak
versus non-outbreak, or US versus non-US geography.
A single study reported risk factors for incident pneu-
monia in an unvaccinated study population [27]. These
risk factors included activities of daily living status and
the presence of swallowing disorders, ischemic heart dis-
ease, or dementia [27].
Discussion
Our systematic review of published literature reporting on
the natural burden of influenza, RSV, and pneumonia
among older adults in LTCFs included 26 studies with
highly variable estimates ranging from 1.21 to 85.2% for
incidence and 1.4 to 55.8% for prevalence across all infec-
tions. Despite the variability in the estimates, these data
suggest that the incidence and prevalence of respiratory
infections are high among older LTCF residents. The
available data underscore the lack of nationally representa-
tive, modern, and large studies of the burden of respira-
tory infections in this important population. While studies
are necessary for all respiratory infection types, studies are
particularly necessary to better understand the epidemi-
ology of influenza among LTCF residents. Without such
well-designed studies to inform interventions, clinical
practice, and policy, an evidence-based approach to the
reduction of the burden of respiratory infections in LTCFs
will be unnecessarily challenging.
This systematic review uncovered several important
themes of the underlying literature on the burden of
respiratory infections in LTCFs.
Nearly all studies had small sample sizes of not more
than a couple hundred LTCF residents, suggesting that
estimates of the incidence and prevalence are unlikely to
generalize broadly. Therefore, the selection of epidemio-
logic studies to inform clinical or policy decision-making,
intervention development or implementation, and other
Table 2 Published Literature on the Burden of Respiratory Syncytial Virus in Long-term Care Facilities
Author, Publication
Year
Study Design Country Study Dates Type of study Age, Mean
(SD)a, in years








Outbreak 79.2 13 / 101 12.9%
Ellis et al., 2003 [31] Retrospective
Cohort
United States August 1, 1995
- July 31, 1999
Non-outbreak Age≥ 65,
100%








United States 2000–2001d Non-outbreak 82.2 (8.4) 3 / 198 1.5%
Caram et al., 2009 [18] Prospective
Cohort
United States January 29, 2008 -
February 26, 2008
Outbreak 70.8 (15.0) 7 / 52 13.5%




Canada 2009, 2010, 2011e Non-outbreak Median 86 (IQR
80–90)
12 / 1072 1.1%
Uršič et al., 2016 [19] Prospective
Cohort
Slovenia December 5, 2011
- May 31, 2012
Non-outbreak Median 84 (IQR
79.8–88.8)
5 / 90 5.6%




Non-outbreak 84.9 (8.9) 21 / 194 10.8%
aIf available and unless another measure is specified
bThe estimates and study participants’ characteristics were calculated among the unvaccinated individuals
cOnly the number of person-years contributed by study sample was reported, not the number of individuals in the sample
dThe published paper stated that study participants were enrolled in September or October and followed to the end of the respiratory viral season
eParticipants were enrolled from mid-February through mid-March in 2000 for the first influenza season and trial. Then, a second trial was initiated in late
December 2000 during a second influenza season, but the time period of enrollment was not reported
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initiatives to intervene on infection risk in LTCFs must
consider sample sizes and study designs.
Studies of risk factors for incident respiratory infections
in LTCFs were surprisingly scarce. Identifying predictors
and developing tools to evaluate the respiratory infection
risk of patients should be a focus of additional research.
Existing datasets like linked Medicare claims and Minimum
Data Set assessments could be used to identify predictors
in routinely collected data. The increasing availability of
electronic medical records in LTCFs could then support in-
dividual patient models for specific infections. For instance,
once predictors have been empirically identified, electronic
medical record data could be used to output the 6-month
probability of developing pneumonia for each patient. Akin
to the lack of studies examining predictors, no studies
meeting our search criteria attempted to quantify the
effects of incident respiratory infections on outcomes like
healthcare costs, hospital readmissions, disability, or mor-
tality. While respiratory infections certainly have a negative
impact on all such outcomes, a better understanding of the
magnitude of those effects and how they vary across sub-
groups of LTCF residents would be valuable for developing
and implementing interventions to reduce the burden of
respiratory infections.
The literature on respiratory infections presented sev-
eral challenges to interpretation. Seven articles included in
this review focused on outbreaks, which give rise to esti-
mates that are likely higher than typically observable in
LTCFs. The definition of an outbreak also varies markedly
across studies by geography, type of respiratory infection,
population involved, time, and more [43]. Many outbreaks
are generally defined as an infection incidence exceeding
an expected rate. Interestingly, few data are available to
quantify or provide guidance about what an accurate and
reliable estimate of an “expected rate” is. Studies reporting
higher incidence rates (e.g., > 15%) may actually be out-
break studies even if they were not labeled as such. Con-
verse to the potential overestimation of infection rates by
outbreak data, data sources like administrative claims cap-
ture only some of the most severe infections and likely
underestimate the burden of respiratory infections.
Administrative data may identify even fewer respiratory
infection events among LTCF residents because signs and
symptoms of acute infection are often not proportional to
the severity of illness [43]. Interpretation of the literature
is further complicated by the atypical presentation of in-
fections in frail older adults [44]. For example, LTCF resi-
dents may have pneumonia without cough, chest pain, or
fever; tachypnea or confusion may be the only indicators
[45, 46]. Atypical presentation is even more likely among
those who are very old, cognitively impaired, multimorbid,
or frail. The atypical presentation of respiratory infections
in LTCFs can therefore lead to underdiagnosis and artifi-
cially low prevalence and incidence estimates.
The majority of the included studies reported respira-
tory infection incidence data and most were from North
America. The focus on North America may have re-
sulted, in part, from our focus on LTCFs unassociated
with a hospital and the differences in LTCF structure or
care systems between geographic regions or countries
[47]. Places other than North America have many hos-
pital-based LTCFs or have few LTCFs due to the use of
alternative care settings. If LTCFs in North America
have more resources than LTCFs in other geographic re-
gions, the large number of North American studies
could meaningfully impact estimates. LTCFs with more
resources are more likely to have physician extenders
(e.g., nurse practitioners, physician’s assistants) and lar-
ger amounts of staff to help implement interventions to
reduce respiratory infections. LTCFs with more re-
sources may also be more likely to have private rooms,
which are better at limiting or containing the spread of
infections. However, the incidence of RSV did not ap-
pear to differ between studies conducted in North
America versus elsewhere. In aggregate, the burden of
pneumonia also did not differ markedly between North
America and other places, but when stratified on meas-
ure of occurrence, the incidence was higher in North
America while the prevalence was higher in countries
outside North America. Future studies should examine
the influence of LTCF resources and characteristics on
respiratory infection rates.
Our findings support the idea that healthcare providers
should promote immunization against influenza and
pneumonia, and rigorously implement prevention prac-
tices to avoid the spread of infections, particularly in un-
vaccinated populations [48]. Vaccination rates in LTCFs
have been slowly increasing over time, but many residents
remain unvaccinated and considerable improvement in
vaccination rates is possible [49]. Of relevance, the small
number of influenza studies precluded a meaningful ana-
lysis of time trends for influenza in our review, but no lin-
ear or other time trends for pneumonia or RSV were
apparent, even after stratifying on location of study (North
America versus not), type of study (outbreak or non-out-
break), or estimate of occurrence (incidence or preva-
lence). Our results suggest that a rigorous examination of
how time trends in vaccination rates have impacted time
trends in respiratory infections may be necessary to
understand the absence of a relationship between the two
across included studies. The results of our review also sug-
gest that policy-makers should consider LTCF-specific
policies to improve uptake of preventive interventions for
reducing the burden of respiratory infections [48].
Our systematic review findings must be interpreted in
light of several potential limitations and considerations.
One potential limitation of the review is the search restric-
tions we introduced to focus the review. For example, we
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only included articles that were published in English. Al-
though we included studies from several geographic loca-
tions, language barriers may have resulted in the exclusion
of eligible studies of highly unvaccinated populations.
A second potential limitation is that we may have unin-
tentionally included studies with populations offered anti-
viral medications during the study period if authors elected
not to report antiviral use in their published manuscripts
on influenza in LTCFs. The risk of including antiviral-ex-
posed residents is especially high for studies of outbreaks,
which are an indication for antiviral use. Including anti-
viral-exposed populations in our review would lead to an
underestimation of the burden of infection. This concern is
mitigated by research demonstrating that chemoprophy-
laxis with antivirals may be less effective for influenza pre-
vention in unvaccinated residents of LTCFs [50].
A third potential limitation of our review was its focus on
identifying the burden of respiratory infections among LTCF
residents in the absence of intervention, particularly vaccin-
ation. This focus was necessary to understand the potential
impact of new interventions and policies. Furthermore,
many LTCF residents are unvaccinated and immunization
rates remain unsatisfactorily low in LTCFs. This creates an
essential need to understand the natural burden of respira-
tory infections and guide further prevention efforts as well
as help make a more compelling argument for encourage-
ment of vaccination by providers [51, 52]. However, since
the use of vaccines has increased over time in LTCFs, our
review may have unintentionally included an older evidence
base that is less generalizable to contemporary LTCF resi-
dents. Related to this limitation is the challenge that many
studies included populations of unvaccinated residents
whose data was not presented separately from that of vacci-
nated residents. To remain within the scope of our review,
we excluded studies that did not distinguish vaccinated and
unvaccinated individuals. In doing so, we may have isolated
a less generalizable evidence base.
An additional important potential limitation of our sys-
tematic review is that respiratory infections other than influ-
enza, RSV, and pneumonia occur in LTCFs and can be
important. We selected influenza, RSV, and pneumonia as
the focus because of their clinical importance, but future re-
views and research should consider other respiratory infec-
tions as well as the etiology and pathogens involved (i.e.,
specific organisms or strains). Other respiratory viruses of
potential future interest should include adenovirus, corona-
virus, metapneumovirus, parainfluenza virus, and rhinovirus.
In older adults, respiratory viruses can also produce gastro-
intestinal symptoms, and therefore may go unrecognized as
having a respiratory etiology. Given the breadth of respira-
tory infections and pathogens that are important in LTCFs,
establishing a comprehensive surveillance program for the
LTCF population may prove highly valuable for guiding clin-
ical care and future interventions [53, 54].
Conclusions
Limited data exist about the burden of respiratory infec-
tions among older adults in LTCFs. Most prior studies were
not nationally representative, recent, or large enough to
generate precise estimates. Well-designed studies are there-
fore needed to credibly identify the burden of respiratory
infections in LTCFs. Furthermore, large and well-designed
studies are still necessary to understand the determinants
of increased respiratory infection risk in LTCFs as well as
subsequent outcomes. Such data could ultimately help to
reduce the burden of respiratory infections in LTCFs by
informing intervention development, evidence-based clin-
ical practice, and effective policymaking.
Additional file
Additional file 1: Table S1. PubMed Search Strategy. Table S2. EMBASE
search strategy. (DOCX 15 kb)
Abbreviations
LTCF: long-term care facility; RCT: randomized controlled trial; RSV: respiratory




Concept and design: AC, ARZ. Acquisition, analysis, or interpretation of data:
All authors. Drafting of the manuscript: AC, ARZ. Critical revision of the
manuscript for important intellectual content: All authors. Obtained funding:
ARZ, VM, SG. Supervision: ARZ, VM, SG. Other - Literature search and
screening; data extraction: AC, ARZ, KWM, RVA. Approval of the submitted
version of the manuscript: All authors. Accountable for personal
contributions to the work and questions related to any aspect of the work:
All authors. All authors read and approved the final manuscript.
Funding
Sanofi Pasteur provided a research grant to the authors’ institution to
support this systematic review as part of a larger project aiming to estimate
the burden of infections in long-term care. The authors’ institution retained
the right to publish and publicly present all results. Sanofi Pasteur was not in-
volved in establishing the scope of the systematic review, creating the initial
protocol, extracting data, or performing qualitative analysis, but was involved
in suggesting edits to the final review protocol and reviewing the final
manuscript. Incorporation of any edits suggested by Sanofi Pasteur was not
compulsory.
Availability of data and materials
Data sharing is not applicable to this article as no datasets were generated
or analysed during the current study.
Ethics approval and consent to participate
This review did not require institutional review board approval because it
synthesized existing published aggregate data.
Consent for publication
This review did not contain any individual person’s data.
Competing interests
All authors declare no competing interests, conflicts of interest, or financial
ties to disclose, except R.V.A., who discloses that he is an employee of Sanofi
Pasteur.
Childs et al. BMC Geriatrics          (2019) 19:210 Page 8 of 10
Author details
1Department of Epidemiology, Brown University School of Public Health,
Providence, RI, USA. 2Department of Health Services, Policy, and Practice,
Brown University School of Public Health, 121 South Main Street, Box
G-S121-8, Providence, RI 02912, USA. 3Center of Innovation in Long-Term
Services and Supports, Providence Veterans Affairs Medical Center,
Providence, RI, USA. 4Sanofi Pasteur, Swiftwater, PA, USA. 5Faculty of Medical
Sciences, University of Groningen, Groningen, NL, the Netherlands.
Received: 16 May 2019 Accepted: 30 July 2019
References
1. Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am
Thorac Soc. 2014;11(3):404–6.
2. Centers for Disease Control and Prevention. Disease Burden of Influenza.
https://www.cdc.gov/flu/about/disease/burden.htm. Accessed 12 May 2018.
3. Dwyer LL, Harris-Kojetin LD, Valverde RH, Frazier JM, et al. Infections in long-
term care populations in the United States. J Am Geriatr Soc. 2013;61(3):
342–9.
4. Falsey AR, Walsh EE. Respiratory syncytial virus infection in elderly adults.
Drugs Aging. 2005;22(7):577–87.
5. Centers for Disease Control and Prevention. Respiratory Syncytial Virus (RSV):
Older Adults Are at High Risk for Severe RSV Infection. https://www.cdc.gov/
rsv/factsheet-older-adults.html. Accessed 12 May 2018.
6. Meyer KC. The role of immunity in susceptibility to respiratory infection in
the aging lung. Respir Physiol. 2001;128(1):23–31.
7. Ortman JM VV, Hogan H. An Aging Nation: The Older Population in the
United States. The United States Census Bureau 2014. P25–1140.
8. Feng Z, Liu C, Guan X, Mor V. China’s rapidly aging population creates
policy challenges in shaping a viable long-term care system. Health Aff.
2012;31(12):2764–73.
9. Feng Z, Zhan HJ, Feng X, Liu C, et al. An industry in the making: the
emergence of institutional elder care in urban China. J Am Geriatr Soc.
2011;59(4):738–44.
10. Furman CD, Rayner AV, Tobin EP. Pneumonia in older residents of long-
term care facilities. Am Fam Physician. 2004;70(8):1495–500.
11. Dhawan N, Pandya N, Khalili M, Bautista M, et al. Predictors of mortality for
nursing home-acquired pneumonia: a systematic review. Biomed Res Int.
2015;2015:285983.
12. Rainwater-Lovett K, Chun K, Lessler J. Influenza outbreak control practices
and the effectiveness of interventions in long-term care facilities: a
systematic review. Influenza Other Respir Viruses. 2014;8(1):74–82.
13. Brown JG. Nursing Home Vaccination: Reaching Healthy People Goals:
Department of Health and Human Services. Department of Health and
Human Services: Office of Inspector General;2000. OEI-01-99-00010.
14. Byron C Wallace KS, Carla E Brodley, Joseph Lau, Thomas A Trikalinos.
Deploying an interactive machine learning system in an evidence-based
practice center: abstrackr. Proceedings of the 2nd ACM International Health
Informatics Symposium (IHI) 2012:5.
15. Vittinghoff E. Regression methods in biostatistics : linear, logistic, survival,
and repeated measures models. 2nd ed. New York: Springer; 2012.
16. Hamborsky J KA, Wolfe S, eds. Epidemiology and Prevention of Vaccine-
Preventable Diseases. 13th ed. Washington D.C.: centers for disease control
and Prevention; 2015.
17. Johnstone J, Parsons R, Botelho F, Millar J, et al. Immune biomarkers
predictive of respiratory viral infection in elderly nursing home residents.
PLoS One. 2014;9(9):e108481.
18. Caram LB, Chen J, Taggart EW, Hillyard DR, et al. Respiratory syncytial virus
outbreak in a long-term care facility detected using reverse transcriptase
polymerase chain reaction: an argument for real-time detection methods. J
Am Geriatr Soc. 2009;57(3):482–5.
19. Ursic T, Miksic NG, Lusa L, Strle F, et al. Viral respiratory infections in a
nursing home: a six-month prospective study. BMC Infect Dis. 2016;16(1):
637.
20. Hui DS, Woo J, Hui E, Foo A, et al. Influenza-like illness in residential care
homes: a study of the incidence, aetiological agents, natural history and
health resource utilisation. Thorax. 2008;63(8):690–7.
21. Quagliarello V, Ginter S, Han L, Van Ness P, et al. Modifiable risk factors for
nursing home-acquired pneumonia. Clin Infect Dis. 2005;40(1):1–6.
22. Givens JL, Jones RN, Shaffer ML, Kiely DK, et al. Survival and comfort after
treatment of pneumonia in advanced dementia. Arch Intern Med. 2010;
170(13):1102–7.
23. Sund-Levander M, Grodzinsky E, Wahren LK. Gender differences in
predictors of survival in elderly nursing-home residents: a 3-year follow up.
Scand J Caring Sci. 2007;21(1):18–24.
24. Te Wierik MJ, Nguyen DT, Beersma MF, Thijsen SF, et al. An outbreak of
severe respiratory tract infection caused by human metapneumovirus in a
residential care facility for elderly in Utrecht, the Netherlands, January to
march 2010. Euro Surveill. 2012;17:13.
25. Sarabia-Cobo CM, Perez V, de Lorena P, Dominguez E, et al. The incidence
and prognostic implications of dysphagia in elderly patients
institutionalized: a multicenter study in Spain. Appl Nurs Res. 2016;30:e6–9.
26. Fukushima W, Hayashi Y, Mizuno Y, Suzuki K, et al. Selection bias in
evaluating of influenza vaccine effectiveness: a lesson from an observational
study of elderly nursing home residents. Vaccine. 2008;26(50):6466–9.
27. Kikutani T, Tamura F, Tashiro H, Yoshida M, et al. Relationship between oral
bacteria count and pneumonia onset in elderly nursing home residents.
Geriatr Gerontol Int. 2015;15(4):417–21.
28. Centers for Disease Control and Prevention. Impact of influenza on a
nursing home population - New York. Morb Mortal Wkly Rep 1983;
2018(May 12):3.
29. Horman JT, Stetler HC, Israel E, Sorley D, et al. An outbreak of influenza a in
a nursing home. Am J Public Health. 1986;76(5):501–4.
30. Sorvillo FJ, Huie SF, Strassburg MA, Butsumyo A, et al. An outbreak of
respiratory syncytial virus pneumonia in a nursing home for the elderly. J Inf
Secur. 1984;9(3):252–6.
31. Ellis SE, Coffey CS, Mitchel EF Jr, Dittus RS, et al. Influenza- and respiratory
syncytial virus-associated morbidity and mortality in the nursing home
population. J Am Geriatr Soc. 2003;51(6):761–7.
32. Huybrechts KF, Rothman KJ, Silliman RA, Brookhart MA, et al. Risk of death
and hospital admission for major medical events after initiation of
psychotropic medications in older adults admitted to nursing homes. CMAJ.
2011;183(7):E411–9.
33. Cartter ML, Renzullo PO, Helgerson SD, Martin SM, et al. Influenza outbreaks
in nursing homes: how effective is influenza vaccine in the institutionalized
elderly? Infect Control Hosp Epidemiol. 1990;11(9):473–8.
34. Konetzka RT, Spector W, Shaffer T. Effects of nursing home ownership type
and resident payer source on hospitalization for suspected pneumonia.
Med Care. 2004;42(10):1001–8.
35. Won A, Lapane KL, Vallow S, Schein J, et al. Long-term effects of analgesics
in a population of elderly nursing home residents with persistent
nonmalignant pain. J Gerontol A Biol Sci Med Sci. 2006;61(2):165–9.
36. Aparasu RR, Chatterjee S, Chen H. Risk of pneumonia in elderly nursing
home residents using typical versus atypical antipsychotics. Ann
Pharmacother. 2013;47(4):464–74.
37. Doi I, Nagata N, Tsukagoshi H, Komori H, et al. An outbreak of acute respiratory
infections due to human respiratory syncytial virus in a nursing home for the
elderly in Ibaraki, Japan, 2014. Jpn J Infect Dis. 2014;67(4):326–8.
38. Deguchi Y, Takasugi Y. Efficacy of influenza vaccine in the elderly: reduction
in risks of mortality and morbidity during an influenza a (H3N2) epidemic
for the elderly in nursing homes. Int J Clin Lab Res. 2000;30(1):1–4.
39. McElhaney JE, Gravenstein S, Cole SK, Davidson E, et al. A placebo-
controlled trial of a proprietary extract of north American ginseng (CVT-
E002) to prevent acute respiratory illness in institutionalized older adults. J
Am Geriatr Soc. 2004;52(1):13–9.
40. Wu MP, Lin PF, Lin KJ, Sun RS, et al. Integrated care for severely disabled
long-term care facility residents: is it better? Arch Gerontol Geriatr. 2010;
50(3):315–8.
41. Langmore SE, Skarupski KA, Park PS, Fries BE. Predictors of aspiration
pneumonia in nursing home residents. Dysphagia. 2002;17(4):298–307.
42. Rummukainen ML, Makela M, Noro A, Finne-Soveri H, et al. Assessing
prevalence of antimicrobial use and infections using the minimal data set in
Finnish long-term care facilities. Am J Infect Control. 2013;41(4):e35–7.
43. Yoshikawa TT, Norman DC. Geriatric infectious diseases: current concepts on
diagnosis and management. J Am Geriatr Soc. 2017;65(3):631–41.
44. Norman DC. Clinical features of infection in older adults. Clin Geriatr Med.
2016;32(3):433–41.
45. Ewig S, Klapdor B, Pletz MW, Rohde G, et al. Nursing-home-acquired
pneumonia in Germany: an 8-year prospective multicentre study. Thorax.
2012;67(2):132–8.
Childs et al. BMC Geriatrics          (2019) 19:210 Page 9 of 10
46. Wester AL, Dunlop O, Melby KK, Dahle UR, et al. Age-related differences in
symptoms, diagnosis and prognosis of bacteremia. BMC Infect Dis. 2013;13:346.
47. Sanford AM, Orrell M, Tolson D, Abbatecola AM, et al. An international
definition for “nursing home”. J Am Med Dir Assoc. 2015;16(3):181–4.
48. Jump RLP, Crnich CJ, Mody L, Bradley SF, et al. Infectious diseases in older
adults of long-term care facilities: update on approach to diagnosis and
management. J Am Geriatr Soc. 2018;66(4):789–803.
49. Black CL, Williams WW, Arbeloa I, Kordic N, et al. Trends in influenza and
pneumococcal vaccination among US nursing home residents, 2006-2014. J
Am Med Dir Assoc. 2017;18(8):735 e731–14.
50. Ambrozaitis A, Gravenstein S, van Essen GA, Rubinstein E, et al. Inhaled zanamivir
versus placebo for the prevention of influenza outbreaks in an unvaccinated
long-term care population. J Am Med Dir Assoc. 2005;6(6):367–74.
51. Centers for Disease Control and Prevention. 2016–17 Influenza Season Nursing
Home Vaccination Coverage Dashboard. https://www.cdc.gov/flu/fluvaxview/
nursinghome/report1617/reportii/index.html. Accessed 11 Nov 2018.
52. Singleton JA, Santibanez TA, Wortley PM. Influenza and pneumococcal
vaccination of adults aged > or = 65: racial/ethnic differences. Am J Prev
Med. 2005;29(5):412–20.
53. Beck-Sague C, Villarino E, Giuliano D, Welbel S, et al. Infectious diseases and
death among nursing home residents: results of surveillance in 13 nursing
homes. Infect Control Hosp Epidemiol. 1994;15(7):494–6.
54. Engelhart ST, Hanses-Derendorf L, Exner M, Kramer MH. Prospective
surveillance for healthcare-associated infections in German nursing home
residents. J Hosp Infect. 2005;60(1):46–50.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Childs et al. BMC Geriatrics          (2019) 19:210 Page 10 of 10
